Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

TREM-1 inhibition attenuates inflammation and tumor within the colon.

Zhou J, Chai F, Lu G, Hang G, Chen C, Chen X, Shi J.

Int Immunopharmacol. 2013 Oct;17(2):155-61. doi: 10.1016/j.intimp.2013.06.009. Epub 2013 Jun 25.

PMID:
23810411
2.

Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response.

Correale C, Genua M, Vetrano S, Mazzini E, Martinoli C, Spinelli A, Arena V, Peyrin-Biroulet L, Caprioli F, Passini N, Panina-Bordignon P, Repici A, Malesci A, Rutella S, Rescigno M, Danese S.

Gastroenterology. 2013 Feb;144(2):346-356.e3. doi: 10.1053/j.gastro.2012.10.040. Epub 2012 Oct 26.

PMID:
23108068
3.
4.

Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.

Pouyet L, Roisin-Bouffay C, Clément A, Millet V, Garcia S, Chasson L, Issaly N, Rostan A, Hofman P, Naquet P, Galland F.

Inflamm Bowel Dis. 2010 Jan;16(1):96-104. doi: 10.1002/ibd.21031.

PMID:
19572375
5.

DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.

Nam SY, Kim JS, Kim JM, Lee JY, Kim N, Jung HC, Song IS.

Exp Biol Med (Maywood). 2008 Feb;233(2):180-91. doi: 10.3181/0707-RM-186.

PMID:
18222973
6.

Role of TREM-1 in response to Aspergillus fumigatus infection in corneal epithelial cells.

Hu LT, Du ZD, Zhao GQ, Jiang N, Lin J, Wang Q, Xu Q, Cong L, Qiu S.

Int Immunopharmacol. 2014 Nov;23(1):288-93. doi: 10.1016/j.intimp.2014.09.011. Epub 2014 Sep 19.

PMID:
25242387
7.

Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer.

Waldner MJ, Wirtz S, Becker C, Seidel D, Tubbe I, Cappel K, Hähnel PS, Galle PR, Schuler M, Neurath MF.

Inflamm Bowel Dis. 2010 Apr;16(4):559-67. doi: 10.1002/ibd.21107.

PMID:
19785028
8.

Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.

Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H.

Arthritis Rheum. 2009 Jun;60(6):1615-23. doi: 10.1002/art.24554.

9.

Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.

Jauch D, Martin M, Schiechl G, Kesselring R, Schlitt HJ, Geissler EK, Fichtner-Feigl S.

Gut. 2011 Dec;60(12):1678-86. doi: 10.1136/gutjnl-2011-300612. Epub 2011 Sep 23.

PMID:
21948944
10.

Melatonin modulated autophagy and Nrf2 signaling pathways in mice with colitis-associated colon carcinogenesis.

Trivedi PP, Jena GB, Tikoo KB, Kumar V.

Mol Carcinog. 2016 Mar;55(3):255-67. doi: 10.1002/mc.22274. Epub 2015 Jan 16.

PMID:
25598500
12.

Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice.

Shang K, Bai YP, Wang C, Wang Z, Gu HY, Du X, Zhou XY, Zheng CL, Chi YY, Mukaida N, Li YY.

PLoS One. 2012;7(12):e51848. doi: 10.1371/journal.pone.0051848. Epub 2012 Dec 18.

13.

Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.

Josse C, Bouznad N, Geurts P, Irrthum A, Huynh-Thu VA, Servais L, Hego A, Delvenne P, Bours V, Oury C.

Am J Physiol Gastrointest Liver Physiol. 2014 Feb;306(3):G229-43. doi: 10.1152/ajpgi.00484.2012. Epub 2013 Dec 12.

PMID:
24464560
14.

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.

Stolfi C, Rizzo A, Franzè E, Rotondi A, Fantini MC, Sarra M, Caruso R, Monteleone I, Sileri P, Franceschilli L, Caprioli F, Ferrero S, MacDonald TT, Pallone F, Monteleone G.

J Exp Med. 2011 Oct 24;208(11):2279-90. doi: 10.1084/jem.20111106. Epub 2011 Oct 10.

16.

Strategic compartmentalization of Toll-like receptor 4 in the mouse gut.

Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y.

J Immunol. 2003 Apr 15;170(8):3977-85.

17.

Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.

Bian Z, Li L, Cui J, Zhang H, Liu Y, Zhang CY, Zen K.

J Pathol. 2011 Dec;225(4):544-53. doi: 10.1002/path.2907. Epub 2011 May 18.

PMID:
21590770
18.

Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.

Peng XD, Wu XH, Chen LJ, Wang ZL, Hu XH, Song LF, He CM, Luo YF, Chen ZZ, Jin K, Lin HG, Li XL, Wang YS, Wei YQ.

J Pharmacol Exp Ther. 2010 Jan;332(1):46-56. doi: 10.1124/jpet.109.153494. Epub 2009 Oct 14.

19.

The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.

Tokuyama H, Ueha S, Kurachi M, Matsushima K, Moriyasu F, Blumberg RS, Kakimi K.

Int Immunol. 2005 Aug;17(8):1023-34. Epub 2005 Jul 6.

PMID:
16000328
20.

Up-regulation of Gr1+CD11b+ population in spleen of dextran sulfate sodium administered mice works to repair colitis.

Zhang R, Ito S, Nishio N, Cheng Z, Suzuki H, Isobe K.

Inflamm Allergy Drug Targets. 2011 Feb;10(1):39-46.

PMID:
21184649

Supplemental Content

Support Center